R&D of High-Value-Added, Differentiated Products Leveraging Proprietary Technologies
First written in FY2016. 25 of 31 entries say "Restated". Latest entry: 2026-08-10.
23 other companies' latest entry also says "Advanced".
- 2026-08-10AdvancedEarnings
「We also aim to bring to market at an early stage functional foods for which stable demand is expected, cosmetics using materials designed and developed for regenerative medicine, desserts including ice cream made with functional food materials, biomaterials being developed through industry-academia collaboration, and next-generation materials.」
The company specifically lists functional foods, materials related to regenerative medicine, biomaterials and next-generation materials as products it aims to commercialize early. - FY2026AdvancedAnnual report
「The company has expanded sample work for its development products, including solvent-soluble polyimide, functional adhesive sheets, acrylic resin adhesives, magnetorheological fluids and functional thickening polysaccharides, and has received favorable evaluations by moving from seed-based development toward needs-based development that incorporates customer requirements. In addition, development of biomaterials is producing results through collaboration among industry, government and academia, and the company has begun providing samples.」
The company expanded sample work for multiple development products and began providing biomaterial samples as a result of collaboration among industry, government and academia. R&D expenses were ¥416 million. - FY2026-H1AdvancedAnnual report
「Although the company promoted the commercialization of multifunctional coagulants and retention aids incorporating a new polymer that had received high recognition in the pulp and paper industry, including winning the Paper and Pulp Technology Association's Sasaki Award,」
The filing states that the research on multifunctional coagulants and retention aids using a new polymer was recognized by the industry and that specific R&D progress was made toward commercializing the products. - FY2025-H1RestatedAnnual report
「The Group's total R&D expenses for the current interim consolidated accounting period were ¥208 million. There were no material changes in the status of the Group's R&D activities during the current interim consolidated accounting period.」
The company recorded R&D expenses of ¥208 million and states that there have been no material changes in its R&D activities. - FY2024-Q3RestatedAnnual report
「The Group's total R&D expenses for the cumulative third quarter of the current consolidated fiscal year were ¥299 million. There were no material changes in the status of the Group's R&D activities during the cumulative third quarter of the current consolidated fiscal year.」
The company recorded R&D expenses of ¥299 million and states that there have been no material changes in its R&D activities. - FY2024-Q2RestatedAnnual report
「The Group's total R&D expenses for the cumulative second quarter of the current consolidated fiscal year were ¥201 million. There were no material changes in the status of the Group's R&D activities during the cumulative second quarter of the current consolidated fiscal year.」
The company recorded R&D expenses of ¥201 million and states that there have been no material changes in its R&D activities. - FY2024-Q1RestatedAnnual report
「The Group's total R&D expenses for the cumulative first quarter of the current consolidated fiscal year were ¥94 million. There were no material changes in the status of the Group's R&D activities during the cumulative first quarter of the current consolidated fiscal year.」
The company recorded R&D expenses of ¥94 million and states that there have been no material changes in its R&D activities. - FY2023-Q3RestatedAnnual report
「The Group's total R&D expenses for the cumulative third quarter of the current consolidated fiscal year were ¥277 million. There were no material changes in the status of the Group's R&D activities during the cumulative third quarter of the current consolidated fiscal year.」
The company recorded R&D expenses of ¥277 million and states that there have been no material changes in its R&D activities. - FY2023-Q2RestatedAnnual report
「The Group's total R&D expenses for the cumulative second quarter of the current consolidated fiscal year were ¥185 million. There were no material changes in the status of the Group's R&D activities during the cumulative second quarter of the current consolidated fiscal year.」
The company recorded R&D expenses of ¥185 million and states that there have been no material changes in its R&D activities. - FY2023-Q1RestatedAnnual report
「The Group's total research and development expenditure for the three months ended 30 June was ¥91 million. There were no material changes in the status of the Group's research and development activities during the three months ended 30 June.」
The company recorded R&D expenses of ¥91 million and states that there have been no material changes in its R&D activities. - FY2022-Q3RestatedAnnual report
「The Group's total research and development expenditure for the nine months ended 31 December was ¥278 million. There were no material changes in the status of the Group's research and development activities during the nine months ended 31 December.」
The company recorded research and development expenditure of ¥278 million and stated that there were no material changes in the status of its research and development activities. - FY2022-Q2RestatedAnnual report
「The Group's total research and development expenditure for the six months ended 30 September was ¥184 million. There were no material changes in the status of the Group's research and development activities during the six months ended 30 September.」
The company recorded research and development expenditure of ¥184 million and stated that there were no material changes in the status of its research and development activities. - FY2022-Q1RestatedAnnual report
「The Group's total research and development expenditure for the three months ended 30 June was ¥90 million. There were no material changes in the status of the Group's research and development activities during the three months ended 30 June.」
The company recorded research and development expenditure of ¥90 million and stated that there were no material changes in the status of its research and development activities. - FY2021-Q3RestatedAnnual report
「The Group's total research and development expenditure for the nine months ended 31 December was ¥266 million. There were no material changes in the status of the Group's research and development activities during the nine months ended 31 December.」
The company recorded research and development expenditure of ¥266 million and stated that there were no material changes in the status of its research and development activities. - FY2021-Q2RestatedAnnual report
「The Group's total research and development expenditure for the six months ended 30 September was ¥175 million. There were no material changes in the status of the Group's research and development activities during the six months ended 30 September.」
The company recorded research and development expenditure of ¥175 million and stated that there were no material changes in the status of its research and development activities. - FY2021-Q1RestatedAnnual report
「The Group's total research and development expenditure for the three months ended 30 June was ¥89 million. There were no material changes in the status of the Group's research and development activities during the three months ended 30 June.」
The company recorded research and development expenditure of ¥89 million and stated that there were no material changes in the status of its research and development activities. - FY2020-Q3RestatedAnnual report
「The Group's total research and development expenditure for the nine months ended 31 December was ¥257 million. There were no material changes in the status of the Group's research and development activities during the nine months ended 31 December.」
The company recorded research and development expenditure of ¥257 million and stated that there were no material changes in the status of its research and development activities. - FY2020-Q2AdvancedAnnual report
「Amid intense competition with other companies, sales of industrial disinfectants declined, but sales of papermaking chemicals increased 9.2% as the launch of products with improved quality and functionality led to new adoptions.」
The company launched products with improved quality and functionality, reporting progress in product development and market launch through new adoptions and a 9.2% increase in revenue. - FY2020-Q1RestatedAnnual report
「The Group's total research and development expenditure for the three months ended 30 June was ¥82 million. There were no material changes in the status of the Group's research and development activities during the three months ended 30 June.」
The company recorded research and development expenditure of ¥82 million and stated that there were no material changes in the status of its research and development activities. - FY2019-Q3RestatedAnnual report
「The Group's total research and development expenditure for the nine months ended 31 December was ¥257 million. There were no material changes in the status of the Group's research and development activities during the nine months ended 31 December.」
The company recorded research and development expenditure of ¥257 million and stated that there were no material changes in the status of its research and development activities. - FY2019-Q2RestatedAnnual report
「The Group's total research and development expenditure for the six months ended 30 September was ¥169 million. There were no material changes in the status of the Group's research and development activities during the six months ended 30 September.」
The company recorded research and development expenditure of ¥169 million and stated that there were no material changes in the status of its research and development activities. - FY2019-Q1RestatedAnnual report
「The Group's total research and development expenditure for the three months ended 30 June was ¥86 million. There were no material changes in the status of the Group's research and development activities during the three months ended 30 June.」
The company recorded research and development expenditure of ¥86 million but stated that there were no material changes in the status of its research and development activities. - FY2018-Q3RestatedAnnual report
「The Group's total research and development expenditure for the nine months ended 31 December was ¥259 million. There were no material changes in the status of the Group's research and development activities during the nine months ended 31 December.」
The company recorded research and development expenditure of ¥259 million and stated that there were no material changes in the status of its research and development activities. - FY2018-Q2RestatedAnnual report
「The Group's total research and development expenditure for the six months ended 30 September was ¥175 million. There were no material changes in the status of the Group's research and development activities during the six months ended 30 September.」
The company recorded research and development expenditure of ¥175 million and stated that there were no material changes in the status of its research and development activities. - FY2018-Q1RestatedAnnual report
「The Group's total research and development expenditure for the three months ended 30 June was ¥86 million. There were no material changes in the status of the Group's research and development activities during the three months ended 30 June.」
The company recorded research and development expenditure of ¥86 million but stated that there were no material changes in the status of its research and development activities. - FY2017AdvancedAnnual report
「As a result of its research, the protective film used as a plating mask for special substrates in electronic component manufacturing has been highly regarded in the market and has been adopted in the manufacture of the latest smartphone-related electronic products. In addition, the company's proprietary light-shielding film with enhanced optical functionality has come to be regarded as an important component for increasing the added value of the latest digital imaging equipment models.」
The company describes concrete progress in its research and development results, including adoption in smartphone-related products and positioning as a component for digital imaging equipment. Total research and development expenditure was ¥357 million. - FY2017-Q3RestatedAnnual report
「The Group's total research and development expenditure for the nine months ended 31 December was ¥270 million. There were no material changes in the status of the Group's research and development activities during the nine months ended 31 December.」
The company disclosed research and development expenditure of ¥270 million while stating that there were no material changes in the status of its activities. - FY2017-Q3RestatedAnnual report
「The company aims to expand sales and its business scope through a differentiation strategy for coating products and high-performance resin products, and the market launch of newly developed high-value-added products,」
The company has reiterated its plans to expand sales and its business scope through the market launch of differentiated products and high-value-added newly developed products. - FY2017-Q2RestatedAnnual report
「The company aims to expand sales and its business scope through a differentiation strategy for coating products and high-performance resin products, and the market launch of newly developed high-value-added products,」
The company has reiterated its policy of expanding sales and its business areas through the differentiation and market launch of highly distinctive, high-value-added products. - FY2017-Q1RestatedAnnual report
「The company aims to expand sales and its business scope through a differentiation strategy for coating products and high-performance resin products, and the market launch of newly developed high-value-added products,」
The company continues to pursue expanded sales and broader business areas through the market launch of differentiated products and high-value-added newly developed products. - FY2016First statedAnnual report
「The company successfully developed a groundbreaking solvent-soluble polyimide combining world-class heat resistance and solvent solubility to a high degree. The product has received high praise from users, and the company is actively pursuing market development toward full-scale commercialization.」
The company reports the successful development of a product as a result of research and development of core technologies, and continues to pursue full-scale commercialization and market development.